PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Price to Earnings (2024 - 2025)

Updated

PharmaCyte Biotech's (PMCB) Price to Earnings stood at 0.36 in fiscal Q4 2025 (quarter ended Apr 30, 2025), down 60.7% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Price to Earnings (2024 - 2025) Analysis & Trends

Starting with fiscal Q1 2025, PharmaCyte Biotech's Price to Earnings history includes 4 quarters.

  • Per Business Quant, the preceding three fiscal quarters came in at 0.92 (Q3 2025), 1.34 (Q2 2025) and 1.49 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 0.36
Jan 31, 2025 0.92
Oct 31, 2024 1.34
Jul 31, 2024 1.49
API Access

PharmaCyte Biotech Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PMCB&period=max&api_key=YOUR_API_KEY